RAPID MICRO BIOSYSTEMS, INC. Item 2.02 Financial Statements and Exhibits.
On
The information furnished under this Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended ("the "Securities Act"), or the Exchange Act, except as otherwise expressly stated in such filing.
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits. Exhibit No. Description 99.1* Press Release ofRapid Micro Biosystems, Inc. datedJanuary 11, 2023 104 Cover Page Interactive Data File (formatted as inline XBRL).
________________________________________________
*Furnished herewith
Cautionary Statement Regarding Forward-Looking Statements
This Current Report on Form 8-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this Current Report on Form 8-K that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements relating to guidance on financial results for the fourth fiscal quarter and full year 2022; expectations regarding the Company's preliminary commercial revenue outlook for the full year 2023; and the Company's expectations for future revenue and growth.
In some cases, you can identify forward-looking statements by terminology such
as "outlook," "aim," "anticipate," "assume," "believe," "contemplate,"
"continue," "could," "due," "estimate," "expect," "goal," "intend," "may,"
"objective," "plan," "predict," "potential," "positioned," "seek," "should,"
"target," "will," "would" and other similar expressions that are predictions of
or indicate future events and future trends, or the negative of these terms or
other comparable terminology, although not all forward-looking statements
contain these words. Forward-looking statements involve known and unknown risks,
uncertainties and assumptions which may cause actual results to differ
materially from any results expressed or implied by any forward-looking
statement, including, but not limited to, the impact of macroeconomic volatility
and COVID-19 and its variants on the Company's business and operations,
including further delays in placements and validation of new systems; the
Company's significant losses since inception; the Company's ability to meet its
publicly announced guidance and other expectations about its business and
operating results; the Company's ability to manage our future growth
effectively; the Company's limited experience in marketing and sales and the
effectiveness of its sales processes; the Company's need to develop new products
and adapt to technological changes; the Company's ability to establish and
maintain its position as a leading provider of automated microbial quality
control testing; the Company's ability to maintain its manufacturing facilities;
risks related to third-parties; the Company's ability to retain key management
and other employees; risks related to regulatory and intellectual property
matters; risks related to supply chain disruptions and the impact of inflation;
and the other important factors outlined under the caption "Risk Factors" in the
Company's Annual Report on Form 10-K, filed with the
--------------------------------------------------------------------------------
© Edgar Online, source
